Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2026-01-07 @ 10:54 AM
Study NCT ID:
NCT05154734
Status:
COMPLETED
Last Update Posted:
2024-10-16
First Post:
2021-12-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders
Sponsor:
Tianjin Medical University General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-09
Completion Date Type:
ACTUAL
First Submit Date:
2021-12-07
First Submit QC Date:
None
Study First Post Date:
2021-12-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-13
Last Update Post Date:
2024-10-16
Last Update Post Date Type:
ACTUAL